| 摘要 |
<p>Orally administrable gallium compositions are disclosed comprising a gallium complex in which each ligand is provided by the same or a different compound selected from the group consisting of 3-hydroxy-4-pyrones in which one or more of the hydrogen atoms attached to ring carbon atoms are optionally replaced by a hydrocarbon group of 1 to 6 carbon atoms, wherein said composition inhibits dissociation of the gallium complex in the stomach while allowing release of the gallium complex in the intestine. The compositions are used in the treatment of bone calcium disorders, for chemotherapeutic purposes and for radiographic imaging.</p> |
